Moderna allowed as the 4th vaccine for emergency use in India

DGCI approved Cipla to import Moderna’s COVID-19 vaccine for emergency use in India. Moderna becomes the fourth vaccine after Covishield, Covaxin, and Sputnik.

Moderna is one of the two vaccines received by 120 million Americans and so far no major repercussions have been identified. Moderna is said to be 90% effective against COVID-19.

As for Pfizer, the company’s CEO Albert Bourla issued a statement about the progress of approval in India which is said to be in its final stages. The rollout for the foreign vaccines had been stalled over the conditions of foreign countries to waive their right to indemnify from liabilities raised due to an adverse effect of the vaccine.

Disclaimer: The aforementioned feature is an automated post and is yet to be managed by an approved member. The Woodward Journal does not assume any liability and responsibility for the same. 


Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp


Slide 1
Follow The Woodward Journal on Instagram!

The Woodward Journal's Instagram profile presents visual presentation of the latest editorials on top coverages and headlines from all around the globe.

Slide 2
Follow @TheWoodwardJo on Twitter

Follow The Woodward Journal's Twitter to receive all the groundbreaking latest content in a concise and opining method.

Slide 3
Join The Woodward Journal's LinkedIn Community!

The Woodward Journal offers growth and learning opportunities. To avail the offers join the Journal's exclusive hiring platform on LinkedIn.

previous arrowprevious arrow
next arrownext arrow

Coronavirus Updates